PCN54 COST-MINIMIZATION ANALYSIS OF FLUDARABINE ASSOCIATED TO ALEMTUZUMAB (FLUCAM) VERSUS THE ASSOCIATION OF FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) IN THE SECOND LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) UNDER THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE

✍ Scribed by N Teich; V Teich; R Benitez; A Schiola

• Book ID: 118610889
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 89 KB
• Volume: 12
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)73291-5